AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients
Clinical trial NCT06489197 · RECRUITING
Trial details
- NCT number
- NCT06489197
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-16
- Primary completion
- 2026-10-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.